COVID-19 is a sudden crisis for organizations across the world and Pharmaceutical & Healthcare companies are no exceptions to it. The outbreak has exposed the industry to sudden risks such as liquidity crunch, supply disruptions, a sudden jump in raw material costs & disarrayed CapEx plans.
Anaplan’s flexible, collaborative and scalable platform, with automatic calculations and updates, can assist your teams to quickly shift their plans & build resilience against future black swan events.